Sat.Feb 18, 2023

article thumbnail

The Tale of the Peace Officer

Colors Make me Happy

Did you know that police officers were once called peace officers? The peace officer’s job was just what you would imagine: to keep communities peaceful. Over time, the culture of policing has shifted from keeping communities peaceful to empowering officers by the state to enforce the law, ensure the safety of citizens, and prevent crimes. From the viewpoint of communities, instead of looking at a police officer as someone they can trust, the police have now turned into someone from the governme

96
article thumbnail

Autoimmune diseases linked to higher risk of atrial fibrillation

Hospital Pharmacy Europe

Having one of several autoimmune diseases have been found to increase the risk of developing new-onset atrial fibrillation over time Patients with autoimmune diseases (AIDs) are at an elevated risk of subsequently developing atrial fibrillation according to the findings of a prospective study by Dutch researchers. Atrial fibrillation (AF) is the most common cardiac arrhythmia and data from 2017 suggests that globally, there were 3.046 million new cases.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Opposite of Good is Our Numbness to Pain

Colors Make me Happy

How it is possible that atrocities such as the Holocaust, Al-Anfal, or Halabja could ever occur? How is it that innocent civilians can be brutalized by law enforcement? Mass displacements of refugees? The Yazidi genocide in Northern Iraq? The Rohingya genocide in Myanmar? Is it because some human beings are intrinsically evil? Many would argue that refugees are nature’s making, no different than natural disasters and not of a man-made catastrophe, such as war.

52
article thumbnail

Risk adjusted net present value: What is the current valuation of Chinook Therapeutics’s Atrasentan Hydrochloride?

Pharmaceutical Technology

Atrasentan Hydrochloride is a small molecule commercialized by Chinook Therapeutics, with a leading Phase III program in IgA Nephropathy (Berger’s Disease). According to Globaldata, it is involved in 24 clinical trials, of which 19 were completed, 2 are ongoing, 1 is planned, and 2 were terminated. GlobalData uses proprietary data and analytics to provide a complete picture of Atrasentan Hydrochloride’s valuation in its risk-adjusted NPV model (rNPV).

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Risk adjusted net present value: What is the current valuation of Relmada Therapeutics’s Esmethadone Hydrochloride?

Pharmaceutical Technology

Esmethadone Hydrochloride is a small molecule commercialized by Relmada Therapeutics, with a leading Phase II program in Treatment Resistant Depression. According to Globaldata, it is involved in 11 clinical trials, of which 8 were completed, and 3 are ongoing. GlobalData uses proprietary data and analytics to provide a complete picture of Esmethadone Hydrochloride’s valuation in its risk-adjusted NPV model (rNPV).

40
article thumbnail

Risk adjusted net present value: What is the current valuation of Novartis’s Gevokizumab?

Pharmaceutical Technology

Gevokizumab is a monoclonal antibody commercialized by Novartis, with a leading Phase I program in Metastatic Renal Cell Carcinoma. According to Globaldata, it is involved in 34 clinical trials, of which 20 were completed, 1 is ongoing, and 13 were terminated. GlobalData uses proprietary data and analytics to provide a complete picture of Gevokizumab’s valuation in its risk-adjusted NPV model (rNPV).